Works matching IS 03424642 AND DT 2018 AND VI 44 AND IP 4


Results: 37
    1

    Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).

    Published in:
    2018
    By:
    • Welte, Tobias;
    • Dellinger, R. Phillip;
    • Ebelt, Henning;
    • Ferrer, Miguel;
    • Opal, Steven M.;
    • Singer, Mervyn;
    • Vincent, Jean-Louis;
    • Werdan, Karl;
    • Martin-Loeches, Ignacio;
    • Almirall, Jordi;
    • Artigas, Antonio;
    • Ignacio Ayestarán, Jose;
    • Nuding, Sebastian;
    • Ferrer, Ricard;
    • Sirgo Rodríguez, Gonzalo;
    • Shankar-Hari, Manu;
    • Álvarez-Lerma, Francisco;
    • Riessen, Reimer;
    • Sirvent, Josep-Maria;
    • Kluge, Stefan
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    10
    11
    12
    13
    14
    15
    17

    Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients.

    Published in:
    2018
    By:
    • La Combe, Béatrice;
    • Bleibtreu, Alexandre;
    • Messika, Jonathan;
    • Fernandes, Romain;
    • Clermont, Olivier;
    • Branger, Catherine;
    • Billard-Pomares, Typhaine;
    • Barnaud, Guilène;
    • Magdoud, Fatma;
    • Eveillard, Matthieu;
    • Kouatchet, Achille;
    • Lasocki, Sigismond;
    • Asfar, Pierre;
    • Corvec, Stéphane;
    • Lakhal, Karim;
    • Armand-Lefevre, Laurence;
    • Wolff, Michel;
    • Timsit, Jean-François;
    • Bourdon, Sandrine;
    • Reignier, Jean
    Publication type:
    Letter
    18
    19
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37